Review: Hippocampal sclerosis in epilepsy: a neuropathology review.
Thom M. · 2014
Read Review: Hippocampal sclerosis in epilepsy: a neuropathology review. by Thom M. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4265206.txt.
Introduction
Maria Thom wrote a solo review of hippocampal sclerosis in epilepsy in Neuropathology and Applied Neurobiology in 2014. Hippocampal sclerosis, a scarring pattern of neuron loss in the hippocampus, is the most common finding in the most common focal epilepsy, mesial temporal lobe epilepsy. A 2013 international classification gave pathologists shared ground, and Thom takes stock.
Certain traits, granule cell spread and mossy fibre sprouting, mark the epilepsy-linked form and help separate it from sclerosis of other causes. What starts the scarring stays unsettled: fever seizures in childhood, genes, inflammation, and early development all have evidence and gaps. Thom argues post-mortem studies add what surgical samples cannot, the whole network's changes and the marks of decades of seizures. Several subtypes likely hide under one name.
Catalog record
| CREATOR | Thom M. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Review: Hippocampal sclerosis in epilepsy: a neuropathology review By Maria Thom Published in: Neuropathology and Applied Neurobiology DOI: 10.1111/nan.12150 ABSTRACT Abstract Hippocampal sclerosis (HS) is a common pathology encountered in mesial temporal lobe epilepsy (MTLE) as well as other epilepsy syndromes and in both surgical and post-mortem practice. The 2013 International League Against Epilepsy (ILAE) classification segregates HS into typical (type 1) and atypical (type 2 and 3) groups, based on the histological patterns of subfield neuronal loss and gliosis. In addition, granule cell reorganization and alterations of interneuronal populations, neuropeptide fibre networks and mossy fibre sprouting are distinctive features of HS associated with epilepsies; they can be useful diagnostic aids to discriminate from other causes of HS, as well as highlighting potential mechanisms of hippocampal epileptogenesis. The cause of HS remains elusive and may be multifactorial; the contribution of febrile seizures, genetic susceptibility, inflammatory and neurodevelopmental factors are discussed. Post-mortem based research in HS, as an addition to studies on surgical samples, has the added advantage of enabling the study of the wider network changes associated with HS, the long-term effects of epilepsy on the pathology and associated comorbidities. It is likely that HS is heterogeneous in aspects of its cause, epileptogenetic mechanisms, network alterations and response to medical and surgical treatments. Future neuropathological studies will contribute to better recognition and understanding of these clinical and patho-aetiological subtypes of HS. Keywords: hippocampal sclerosis, neuropathology, temporal lobe epilepsy INTRODUCTION The hippocampus is the most widely studied brain region in both human and experimental epilepsy. Sclerosis of the hippocampus in epilepsy was first noted as far back as 1825 1 followed by the first detailed study of the segmental patterns of neuronal loss in a series of 90 post-mortem (PM) cases, published by Sommer in 1880 (2, for historical review see 3). In the modern era of epilepsy surgical programmes for the management of drug-resistant epilepsy, hippocampal sclerosis (HS) is one of the commonest pathologies 4. HS is particularly associated with the syndrome of mesial temporal lobe epilepsy (MTLE) but can be seen at PM in other epilepsy syndromes. It's incidence in large epilepsy surgical series varies from 33.6% 5 to 66% 6 and in PM series, HS is identified in between 30.5% and 45% of all epilepsy syndromes and in 56% with the syndrome of MTLE 7,8. Neuropathology research in MTLE/HS has been based largely on human surgical tissues, often in parallel with observations in the numerous experimental models of temporal lobe epilepsy (TLE). It has been directed into causes of HS, the cellular and molecular alterations that render the hippocampus epileptogenic, the identification of biomarkers that could be predictive of outcome following surgery as well as correlation with other comorbidities associated with seizures. This review aims to summarize some of the recent advances in this field which may be of relevance to the diagnostic neuropathologist. HS CRITERIA, CLASSIFICATION AND PATTERNS There have been several schemes to classify subtypes of HS, based on the subfield distribution as well as extent of, hippocampal neuronal loss and gliosis. Other terms used interchangeably for HS include Ammon's Horn sclerosis (strictly refers to neuronal loss in CA1–4 and not the dentate gyrus) and mesial temporal sclerosis (which implies more extended sclerosis of extrahippocampal tissues, such as the amygdala and parahippocampal gyrus). A recent consensus classification system, validated through the neuropathology taskforce of the International League Against Epilepsy (ILAE) 9, aims to incorporate aspects of all previous schemes 10–15 (Table 1), through implementing a reproducible, semiquantitative scale for hippocampal subfield neuronal loss. The main advantages of the ILAE system is that it is based on standard stains (Table 2), so can be universally adopted in any centre, it clearly segregates ‘atypical’ (type 2 and 3) from ‘classical’ HS (type 1) and will reduce over-interpretation of endplate gliosis alone as HS. This new classification relies on patterns of neuronal loss and gliosis as objective measures of sclerosis and does not incorporate other alterations (e.g. mossy fibre sprouting, interneuronal alterations – see below) which may be more difficult to reproduce between laboratories. The obvious benefits of a single system is that it will enable comparisons of data sets between centres and emergence of accurate pathological and electroclinical correlations as well as with advanced magnetic resonance imaging (MRI) sequences 19. At present, for example, there is some evidence that HS patterns could be predictive of seizure history or outcome (as detailed in Table 2); the atypical HS patterns have been associated with poorer seizure-free outcomes 11. There is no evidence to support the proposal that type 2 and 3 evolve to type 1 HS over time. Implementation of this clear framework over the next years, integrated with clinical, genetic and imaging data will enable these issues to be addressed and clearer characterization of different subtypes of medial TLE with distinct aetiologies, network alterations and prognosis, in particular the likelihood of a long-term seizure-free outcome following surgical removal 20. [Table: Summary of the various classification schemes adopted for the patterns of hippocampal sclerosis (HS) in epilepsy in recent eras] [Table: Panel of stains useful in the interpretation of HS in epilepsy; those shown in bold are used in the 2013 ILAE classification of HS 9] The histological hallmarks of HS have long been recognized since the earliest PM and surgical series 2,21. Distinctive histological features, which may aid in the discrimination from other causes of HS (e.g. neurodegeneration or hypoxia-ischaemia) include the sharp cut-off between the sclerotic CA1 and the spared neurones of the subiculum (Figure 1A–C), the typical fibrous, contracted gliosis of CA1 (attesting to the chronicity), granule cell dispersion (GCD) (Figure 1D,E), and scattered hypertrophic neurones (particularly in CA4) (Figure 1F) with cytoplasmic distention by microtubules and neurofilaments and increased dendritic complexity 22,23 (see Table 3). The diagnostic confirmation of HS relies to some extent on the provision by the surgeon of ‘en-bloc’ resections where the hippocampal subfield continuity is intact. In small, fragmented or poorly orientated specimens, confirmation of HS can be challenging 19, but supported through implementation of a small panel of special stains (Table 2). In anterior temporal lobectomy surgical procedures, an average 2 cm of the hippocampal body is resected 27,28. The pattern of sclerosis tends to be uniform along the longitudinal axis within a single surgical specimen in MTLE/HS 18 although variability, in the extent (Figure 1G–J) or distribution of subfield neuronal loss is occasionally seen; for example the pattern may represent type 1 HS at one coronal level and type 2 HS in another. The clinical significance of patchy vs. complete subfield damage in resected specimens is, as yet, uncertain 9. [Figure: Typical pathology features of hippocampal sclerosis in epilepsy. (A) Luxol fast blue/cresyl violet-stained preparation of a surgical sample with subfield neuronal loss involving CA1 and CA4. (B) GFAP preparation confirming dense fibrillary gliosis in CA1 with a sharp cut-off point (arrows) with the adjacent subiculum (SBC) and (C) higher magnification detail of the abrupt transition of gliosis at the CA1/subiculum (arrows). (D) Granule cell dispersion as seen with cresyl violet and (E) with NeuN showing clusters of dispersed granule cells (inset shows reelin-positive interneurones and bipolar cells in the molecular layer). (F) Neurofilament-positive neurones with enlarged cell bodies in